Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v3-FR
Language French French
Date Updated 2021-08-13 2018-08-07
Drug Identification Number 02344408 02344408
Brand name OLUX-E OLUX-E
Common or Proper name Clobestal Proprionate Clobestal Proprionate
Company Name MAYNE PHARMA INC MAYNE PHARMA INC
Ingredients CLOBETASOL PROPIONATE CLOBETASOL PROPIONATE
Strength(s) 0.05% 0.05%
Dosage form(s) AEROSOL, FOAM AEROSOL, FOAM
Route of administration TOPICAL TOPICAL
Packaging size 10 g and 100 g 10 g and 100 g
ATC code D07AD D07AD
ATC description CORTICOSTEROIDS, PLAIN CORTICOSTEROIDS, PLAIN
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2018-09-30 2018-09-30
Actual start date 2018-08-03 2018-08-03
Estimated end date 2019-02-28 2019-02-28
Actual end date 2018-09-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Unable to identify a Canadian distributor Shortage due to difficulties establishing importer/distributor framework for continued supply
Health Canada comments